Three Companies Race for Obesity Drug Approval
The race for an anti-obesity drug intensified Wednesday with the latest mid-stage trial data from Orexigen Therapeutics.
clinical trials
Audiopoint Introduces Phone-Based EHR System
Earlier this month, Audiopoint added its voice to the list of companies developing EHR products.
Melanoma Drug Called a “Breakthrough” After Study
Scientists are calling Plexxikon’s experimental skin cancer drug a “breakthrough” after it successfully shrank tumors in clinical trial patients.
Xenoport Reports Positive Data for Chronic Pain Drug
Most people wouldn’t think that a case of chicken pox could cause chronic pain, but many people across the U.S. feel the effects of this common childhood disease years after the red spots have disappeared.
Building a Better Anthrax Vaccine
Swine flu may be causing a current panic, but eight years ago, our big concern was anthrax.
DATATRAK Awarded Phase III Trial With Top 20 Pharma Company
DATATRAK International, a provider of technical support systems for clinical studies, has been awarded a Phase III clinical trial by the European division of a Global Top 20 pharmaceutical company.
New Developments in Detecting and Treating Alzheimer’s
Every 70 seconds, someone develops Alzheimer’s disease. This startling figure from the Alzheimer’s Association underlines the desperate need for new tools to diagnose and treat this debilitating illness.
Positive Results for Human Genome’s Lupus Drug Benlysta
Biotechnology company Human Genome Sciences reported that its drug candidate Benlysta reduced symptoms of lupus in a long-term clinical trial.
AstraZeneca’s Heart Drug Beats Plavix in Phase III Study
Blood-thinning drug Plavix racks up over $8 billion in annual sales, but the blockbuster medication may have some new competition.
Pantec Reports Success In Transdermal Patch Trials
Some patients fear injections so much that they avoid getting proper medical treatment, sometimes with life-threatening results. Transdermal patches, which administer drugs through the skin, could make the bite of the needle a mere unpleasant memory.